Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.1866 USD
−3.70 M USD
72.10 K USD
4.29 M
About Silo Pharma, Inc.
Sector
CEO
Eric Weisblum
Headquarters
Sarasota
Website
Founded
2010
FIGI
BBG002D1DZ06
Silo Pharma, Inc. is a developmental stage biopharmaceutical company, which engages in the merging of traditional therapeutics with psychedelic research. It seeks to acquire and develop intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs. The company was founded by Eric Weisblum on July 13, 2010 and is headquartered in Sarasota, FL.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SILO is 1.0000 USD — it has increased by 8.88% in the past 24 hours. Watch Silo Pharma, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Silo Pharma, Inc. stocks are traded under the ticker SILO.
SILO stock has risen by 7.68% compared to the previous week, the month change is a −14.79% fall, over the last year Silo Pharma, Inc. has showed a −36.71% decrease.
SILO reached its all-time high on Sep 24, 2014 with the price of 125.0000 USD, and its all-time low was 0.8300 USD and was reached on Nov 22, 2024. View more price dynamics on SILO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SILO stock is 21.44% volatile and has beta coefficient of −1.40. Track Silo Pharma, Inc. stock price on the chart and check out the list of the most volatile stocks — is Silo Pharma, Inc. there?
Today Silo Pharma, Inc. has the market capitalization of 4.04 M, it has decreased by −19.47% over the last week.
Yes, you can track Silo Pharma, Inc. financials in yearly and quarterly reports right on TradingView.
Silo Pharma, Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
SILO net income for the last quarter is −928.81 K USD, while the quarter before that showed −931.78 K USD of net income which accounts for 0.32% change. Track more Silo Pharma, Inc. financial stats to get the full picture.
No, SILO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 30, 2024, the company has 3.00 employees. See our rating of the largest employees — is Silo Pharma, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Silo Pharma, Inc. EBITDA is −4.05 M USD, and current EBITDA margin is −5.35 K%. See more stats in Silo Pharma, Inc. financial statements.
Like other stocks, SILO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Silo Pharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Silo Pharma, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Silo Pharma, Inc. stock shows the sell signal. See more of Silo Pharma, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.